Karin Steinbach

Title: Karin Steinbach: Innovator in Neurodegenerative Disease Treatment

Introduction

Karin Steinbach is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of neurodegenerative disease treatment. Her innovative work focuses on developing methods to treat or prevent conditions such as Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis.

Latest Patents

Karin holds 1 patent for her invention titled "Method of treating or preventing neurodegeneration." This invention relates to a compound that effectively inhibits the function of the TRPM4 ion channel. The patent outlines the use of this compound in treating or preventing various neurodegenerative diseases. Additionally, it provides a pharmaceutical composition that includes a TRPM4 inhibitory compound. The invention also describes in vitro methods for identifying pharmaceutically active compounds useful for treating or preventing neurodegenerative diseases.

Career Highlights

Karin is currently associated with Reprise Pharmaceuticals, Inc., where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating debilitating neurodegenerative conditions.

Collaborations

Karin collaborates with notable colleagues, including Manuel Friese and Benjamin Schattling. Their combined expertise enhances the research and development efforts at Reprise Pharmaceuticals.

Conclusion

Karin Steinbach's innovative contributions to neurodegenerative disease treatment highlight her role as a leading inventor in the pharmaceutical field. Her work promises to advance therapeutic options for patients suffering from these challenging conditions.